Hansa Biopharma: Increase of the number of shares and votes |
December 30, 2022 | December 2022 Bond Updates |
LUND, Sweden, Dec. 30, 2022 /PRNewswire/ -- Hansa Biopharma AB "Hansa" or the "Company", (NASDAQ Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announces that the Company's registered share capital and number of outstanding shares and votes have... |
View more at: https://www.prnewswire.com:443/news-releases/hansa-biopharma-increase-of-the-number-of-shares-and-votes-301711325.html |
Related News |
|